1. Home
  2. DAWN vs MATW Comparison

DAWN vs MATW Comparison

Compare DAWN & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAWN
  • MATW
  • Stock Information
  • Founded
  • DAWN 2018
  • MATW 1850
  • Country
  • DAWN United States
  • MATW United States
  • Employees
  • DAWN N/A
  • MATW N/A
  • Industry
  • DAWN Biotechnology: Pharmaceutical Preparations
  • MATW Metal Fabrications
  • Sector
  • DAWN Health Care
  • MATW Telecommunications
  • Exchange
  • DAWN Nasdaq
  • MATW Nasdaq
  • Market Cap
  • DAWN 624.8M
  • MATW 721.1M
  • IPO Year
  • DAWN 2021
  • MATW 1994
  • Fundamental
  • Price
  • DAWN $9.39
  • MATW $25.06
  • Analyst Decision
  • DAWN Strong Buy
  • MATW
  • Analyst Count
  • DAWN 9
  • MATW 0
  • Target Price
  • DAWN $26.56
  • MATW N/A
  • AVG Volume (30 Days)
  • DAWN 3.4M
  • MATW 367.6K
  • Earning Date
  • DAWN 11-04-2025
  • MATW 11-20-2025
  • Dividend Yield
  • DAWN N/A
  • MATW 4.01%
  • EPS Growth
  • DAWN N/A
  • MATW N/A
  • EPS
  • DAWN N/A
  • MATW N/A
  • Revenue
  • DAWN $133,672,000.00
  • MATW $1,497,689,000.00
  • Revenue This Year
  • DAWN $12.88
  • MATW N/A
  • Revenue Next Year
  • DAWN $48.27
  • MATW N/A
  • P/E Ratio
  • DAWN N/A
  • MATW N/A
  • Revenue Growth
  • DAWN 31.11
  • MATW N/A
  • 52 Week Low
  • DAWN $5.64
  • MATW $18.50
  • 52 Week High
  • DAWN $14.46
  • MATW $32.00
  • Technical
  • Relative Strength Index (RSI)
  • DAWN 60.96
  • MATW 59.18
  • Support Level
  • DAWN $8.16
  • MATW $23.57
  • Resistance Level
  • DAWN $9.77
  • MATW $25.55
  • Average True Range (ATR)
  • DAWN 0.70
  • MATW 0.98
  • MACD
  • DAWN -0.02
  • MATW 0.10
  • Stochastic Oscillator
  • DAWN 45.44
  • MATW 59.32

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

Share on Social Networks: